Trials / Approved For Marketing
Approved For MarketingNCT04776694
Compassionate Use of Dupilumab
- Status
- Approved For Marketing
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Regeneron Pharmaceuticals · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
Provide Compassionate Use of Dupilumab
Detailed description
Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications. Availability will depend on location.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dupilumab |
Timeline
- First posted
- 2021-03-02
- Last updated
- 2025-09-22
Source: ClinicalTrials.gov record NCT04776694. Inclusion in this directory is not an endorsement.